HROW FY 2019 Earnings — Harrow Health, Inc. Revenue & Financial Results | Market Cap Arena

HROWHarrow Health, Inc.

$1B

FY 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$51M+23.7% YoY

Gross Profit

$34M67.3% margin

Operating Income

-$5M-9.4% margin

Net Income

$168,0000.3% margin

EPS (Diluted)

$0.01

Cash Flow

Operating Cash Flow

$950,000

Free Cash Flow

-$887,000

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$59M

Total Liabilities

$32M

Stockholders' Equity

$28M

Cash & Equivalents

$5M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$51M	$41M	+23.7%
Gross Profit	$34M	$25M	+38.5%
Operating Income	-$5M	-$5M	+8.1%
Net Income	$168,000	$15M	-98.9%